Cargando…
Identification of a three-miRNA panel in serum for bladder cancer diagnosis by a diagnostic test
BACKGROUND: Bladder cancer (BC) is the tenth most common cancer in the world. Serum microRNA (miRNA) profiles previously have been reported as non-invasive biomarkers in cancer screening. The non-invasive and reliable diagnostic biomarkers are urgently needed for detecting BC, while cystoscopy is in...
Autores principales: | Li, Rongkang, Xia, Yong, Chen, Xuan, Li, Xinji, Huang, Guocheng, Peng, Xiqi, Liu, Kaihao, Zhang, Chunduo, Li, Mingyang, Lin, Yu, Dong, Jing, Ji, Ling, Lai, Yongqing |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AME Publishing Company
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9189164/ https://www.ncbi.nlm.nih.gov/pubmed/35706801 http://dx.doi.org/10.21037/tcr-21-2611 |
Ejemplares similares
-
Use of a Four-miRNA Panel as a Biomarker for the Diagnosis of Stomach Adenocarcinoma
por: Chen, Xuan, et al.
Publicado: (2020) -
A panel of three serum microRNA can be used as potential diagnostic biomarkers for nasopharyngeal carcinoma
por: Li, Rongkang, et al.
Publicado: (2022) -
Evaluation of Serum miR-17-92 Cluster as Noninvasive Biomarkers for Bladder Cancer Diagnosis
por: Wang, Jingyao, et al.
Publicado: (2021) -
Evaluation of miR‐130 family members as circulating biomarkers for the diagnosis of bladder cancer
por: Wang, Jingyao, et al.
Publicado: (2020) -
Identification of grade-related genes and construction of a robust genomic-clinicopathologic nomogram for predicting recurrence of bladder cancer
por: Peng, Xiqi, et al.
Publicado: (2020)